DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

Frequency defined:  

1-10% 

Headache (6-9%) 

Fatigue (2-5%) 

Diarrhea (2-3%) 

Nausea (1-3%) 

Increased triglyceride levels and insulin resistance, decreased high-density lipoprotein (HDL) levels (1%) 

Insomnia (1%) 

Peripheral edema (1%) 

Weakness (1%) 

<1% 

Bradycardia 

Chest pain 

Dyspnea 

Contraindicated in conditions such as 

Hypersensitivity 

Cardiogenic shock 

Bradychardia 

Severe hepatic impairment 

Pregnancy consideration:  

Not recommended to use in pregnancy 

Pregnancy category: C  

Lactation: The excretion of the drug into the breast milk is not known; not recommended  

Pregnancy category: 

• Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester. 
• Category B: There is no evidence of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women. 
• Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women 
• Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits. 
• Category X: Drugs listed in this category outweigh risks over benefits. These category drugs should be prohibited for pregnant women. 
• Category N: No data is available for the drug under this category. 

 

Patient information leaflet 

Generic Name: nebivolol 

Pronounced: [ ne-BIV-oh-lol]  

Why do we use nebivolol? 

Nebivolol belongs to cardio-selective beta blockers, which is used to treat high blood pressure(hypertension)